The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Chloroquine and hydroxychloroquine as available weapons to fight COVID-19
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“certain treatment suggestions that evolved during this period [76], such as garlic, malaria, and hydroxychloroquine”
From Psychosocial Effects of the COVID-19 Pandemic: Large-scale Quasi-Experimental Study on Social Media (2020) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,592
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, É., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,831
de Wilde, A. H., Jochmans, D., Posthuma, C. C., Zevenhoven-Dobbe, J. C., van Nieuwkoop, S., Bestebroer, T. M., van den Hoogen, B. G., Neyts, J. H., & Snijder, E. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03011-14 · Cited by 731
Fenollar, F., Puéchal, X., & Raoult, D. (2007) · New England Journal of Medicine · doi:10.1056/nejmra062477 · Cited by 651
Self-citationIn vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Keyaerts, E., Vijgen, L., Maes, P., Neyts, J. H., & Ranst, M. A. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 644
New insights into the antiviral effects of chloroquine
Savarino, A., Trani, L. D., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Al‐Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 477
Chloroquine for the 2019 novel coronavirus SARS-CoV-2
Colson, P., Rolain, J., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105923 · Cited by 471
Self-citationRolain, J., Colson, P., & Raoult, D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.05.015 · Cited by 408
Self-citationTreatment of Q Fever Endocarditis
Raoult, D., Houpikian, P., Tissot‐Dupont, H., Riss, J. M., Arditi-Djiane, J., & Brouqui, P. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.2.167 · Cited by 352
Self-citationDesign and Synthesis of Hydroxyferroquine Derivatives with Antimalarial and Antiviral Activities
Biot, C., Daher, W., Leleu‐Chavain, N., Fandeur, T., Khalife, J., Dive, D., & Clercq, E. D. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0601856 · Cited by 318
Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice
Keyaerts, E., Li, S., Vijgen, L., Rysman, E., Verbeeck, J., Ranst, M. A. V., & Maes, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01509-08 · Cited by 311
Barnard, D. L., Day, C. W., Bailey, K. W., Heiner, M., Montgomery, R. A., Lauridsen, L., Chan, P. K. S., & Sidwell, R. W. (2006) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020601700505 · Cited by 210
Kono, M., Tatsumi, K., Imai, A. M., Saito, K., Kuriyama, T., & Shirasawa, H. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.10.011 · Cited by 183
Treatment of classic Whipple's disease: from in vitro results to clinical outcome
Lagier, J., Fenollar, F., Lépidi, H., Giorgi, R., Million, M., & Raoult, D. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt310 · Cited by 150
Self-citationAntibiotic Susceptibility of Tropheryma whipplei in MRC5 Cells
Boulos, A., Rolain, J., & Raoult, D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.747-752.2004 · Cited by 146
Self-citationAzithromycin Inhibits the Replication of Zika Virus
Bosseboeuf, E., Aubry, M., Nhan, T., Pina, J.-J. D., Rolain, J., Raoult, D., & Musso, D. (2018) · Journal of Antivirals & Antiretrovirals · doi:10.4172/1948-5964.1000173 · Cited by 131
Self-citationRaoult, D., Drancourt, M., & Vestris, G. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.8.1512 · Cited by 127
Self-citationAzim, K. F., Ahmed, S. R., Banik, A., Khan, M. M. R., Deb, A., & Somana, S. R. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100367 · Cited by 75
Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo
Takano, T., Katoh, Y., Doki, T., & Hohdatsu, T. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.04.016 · Cited by 60
Lazaridis, C., Vlachogiannis, N. I., Bakogiannis, C., Spyridopoulos, I., Stamatelopoulos, K. S., Kanakakis, I., Vassilikos, V. P., & Stellos, K. (2020) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2020.05.004 · Cited by 60
Diacerein: A potential multi-target therapeutic drug for COVID-19
de Oliveira, P. G., Termini, L., Durigon, E. L., Lepique, A. P., Sposito, A. C., & Boccardo, E. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109920 · Cited by 41
Toumi, M., & Aballéa, S. (2020) · Journal of Market Access & Health Policy · doi:10.1080/20016689.2020.1758390 · Cited by 18
Atere, M., Singh, S., Arora, K., Khan, Z., Muzangwa, L., Bhavsar, U., & Nfonoyim, J. M. (2020) · Case Reports in Medicine · doi:10.1155/2020/9185041 · Cited by 3
Cited by
Sorted by citations
Gautret, P., Lagier, J., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Esteves-Vieira, V., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
Self-citationRetractedPharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
Sanders, J. M., Monogue, M. L., Jodlowski, T. Z., & Cutrell, J. B. (2020) · JAMA · doi:10.1001/jama.2020.6019 · Cited by 2,392
Coronavirus Disease 2019–COVID-19
Dhama, K., Sharun, K., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla‐Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Clinical Microbiology Reviews · doi:10.1128/cmr.00028-20 · Cited by 1,993
COVID‐19 diagnosis and management: a comprehensive review
Pascarella, G., Strumia, A., Piliego, C., Bruno, F., BUONO, R. D., Costa, F., Scarlata, S., & Agrò, F. E. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13091 · Cited by 1,435
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz‐Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,333
Metadata
- Authors
- Colson, P., Rolain, J.-M., Lagier, J.-C., Brouqui, P., & Raoult, D.
- Affiliations
- Aix-Marseille Université (FR)
- Corresponding author
- Raoult, Didier
- Venue
- International Journal of Antimicrobial Agents
- Publisher
- Elsevier BV
- Published
- 2020-04
- Volume
- 55
- Issue
- 4
- Pages
- 105932
- ISSN
- 0924-8579 (ISSN-L)
- PMC
- PMC7135139
- OpenAlex
- W3010277308
- Cited by
- 937
- References
- 26
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 21 · 2023: 45 · 2022: 71 · 2021: 215 · 2020: 564
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- International Journal of Antimicrobial Agents (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IAHU-0003)
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Keywords
- chloroquine, hydroxychloroquine, COVID-19 pandemic, SARS-CoV-2, antimalarial drugs, antiviral therapy
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Adenosine Monophosphate, Alanine, Chloroquine, Hydroxychloroquine, Pneumonia, Viral, Coronavirus, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
